Metraipolis › archive › dc_a78dfb7647ec

Toward Biology-Driven Surveillance After Endometrial Cancer Treatment: A Molecular-Clinical Framework Integrating Recurrence Phenotype — Europe PMC PMID:42122239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42122239
DOI
10.3390/cancers18091443
License (as archived)
solo-consultazione
Archived
2026-11-03T00:52:39.614Z
SHA-256 of the archived text
d9f91c19c1ef4227c50273d308054072ce872fbeccba9b71ef0b87724694e751
Stable URL of this page
https://metraipolis.com/documento/dc_a78dfb7647ec

How to cite

Toward Biology-Driven Surveillance After Endometrial Cancer Treatment: A Molecular-Clinical Framework Integrating Recurrence Phenotype — Europe PMC PMID:42122239 — Europe PMC (en), https://europepmc.org/article/MED/42122239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a78dfb7647ec (Metraipolis archive dc_a78dfb7647ec, sha256 d9f91c19c1ef4227c50273d308054072ce872fbeccba9b71ef0b87724694e751)
BibTeX
@misc{dca78dfb7647ec,
  title = {Toward Biology-Driven Surveillance After Endometrial Cancer Treatment: A Molecular-Clinical Framework Integrating Recurrence Phenotype — Europe PMC PMID:42122239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42122239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a78dfb7647ec; sha256 d9f91c19c1ef4227c50273d308054072ce872fbeccba9b71ef0b87724694e751},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42122239. Agents can read the archived copy with the MCP tool read_document.